At the same time, the specific mechanism of IL-1, IL-2, and INF-γ in SS has been studied in some research works [30], and the current clinical treatment of SS is more focused on IL-17 [31]; therefore, we concentrate more on IL-17 and research on HIF-1α. Here, HIF1A is linked to synovial sarcoma.